COVID-19 Update

Genosity is actively monitoring the situation and taking the necessary steps to address the challenges created by the Coronavirus/COVID-19 pandemic and associated restrictions imposed on both individuals and organizations. Our primary goals are to protect the safety of our staff as well as ensure continuity and quality of the services we provide to our clients. We have had contingencies in place under our business continuity plan where safeguards and risk mitigating strategies have been enacted to protect the well-being of our employees, customers, suppliers and other stakeholders impacted by this pandemic.

At this time, all of our staff members who can work remotely will work from home until further notice to support our laboratory and software services, so that our clients can continue to access our services without interruption or delay.  All essential employees continue to arrive to our laboratory facility. Visitation to our facility is limited to critical visitors who are subject to a prescribed screening program to reduce exposure of our essential laboratory staff.

We are closely monitoring the situation and will provide updates if anything changes. If you have any specific questions, please reach out to your Genosity project manager or email us at

As always, thank you for being our partner and for your continued trust and support as we work through these challenging times together.